Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,246 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Large (15.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (14.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (14.5bn) 0 No activity — 0–15%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (14.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (14.0bn) 0 No activity — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (14.0bn) 1–5 $100K–$1M 0–15% 50%+
Pharmaceuticals & Medical Research Large (13.9bn) -6–10 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (13.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (13.5bn) 0 No activity — 0–15%
Healthcare Services Large (13.5bn) 0 No activity — 15–50%
Healthcare Services Large (13.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (13.2bn) 0 No activity — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals & Medical Research Large (13.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.9bn) 0 No activity — 50%+
IE ICON PLC (ICLR)
Pharmaceuticals & Medical Research Large (12.9bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) 0 No activity — 0–15%
Healthcare Services Large (12.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.5bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (12.4bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (12.3bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (12.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.1bn) 0 No activity — 0–15%
Healthcare Services Large (12.1bn) -1–5 -$10M–$100M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US DaVita Inc (DVA)
Healthcare Services Large (11.7bn) 0 No activity — 15–50%
Healthcare Services Large (11.6bn) 0 No activity — 15–50%
Healthcare Services Large (11.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.6bn) -1–5 -$1M–$10M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.2bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No activity — 0–15%
Healthcare Services Large (10.9bn) 0 No activity — 0–15%
Healthcare Services Large (10.9bn) -1–5 -$100K–$1M -0–15% 0–15%
US Repligen Corp (RGEN)
Healthcare Services Large (10.7bn) 0 No activity — 0–15%
Healthcare Services Large (10.6bn) 0 No activity — 0–15%
Healthcare Services Large (10.6bn) 0 No activity — 0–15%
Healthcare Services Large (10.5bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.2bn) 0 No activity — 0–15%
Healthcare Services Large (10.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (10.1bn) 0 No activity — 15–50%
AU Cochlear Ltd (COH)
Healthcare Services Large (10.1bn) 0 No activity — 0–15%
US Glaukos Corp (GKOS)
Healthcare Services Large (10.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (10.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.9bn) 0 No activity — 50%+
DK Demant A/S (DEMANT)
Healthcare Services Mid (9.8bn) 0 $100K–$1M 0–15% 50%+
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.6bn) 0 No activity — 15–50%
Healthcare Services Mid (9.4bn) 0 No activity — 0–15%
US Masimo Corp (MASI)
Healthcare Services Mid (9.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (9.3bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (9.1bn) 0 No activity — 0–15%
US Insulet Corp (PODD)
Healthcare Services Mid (9.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (8.9bn) 0 No activity — 0–15%
Healthcare Services Mid (8.9bn) -1–5 -$10M–$100M -0–15% 15–50%
US ImmunoGen Inc (IMGN)
Pharmaceuticals & Medical Research Mid (8.7bn) 0 No activity — 0–15%
US Mylan NV (MYL)
Pharmaceuticals & Medical Research Mid (8.6bn) 0 No activity — 0–15%
US Vaxcyte Inc (PCVX)
Pharmaceuticals & Medical Research Mid (8.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.4bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Abivax SA (ABVX)
Pharmaceuticals & Medical Research Mid (8.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%
ES Grifols SA (GRF)
Pharmaceuticals & Medical Research Mid (7.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (7.6bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.5bn) 0 No activity — 0–15%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals & Medical Research Mid (7.4bn) 0 No activity — 50%+
Healthcare Services Mid (7.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No activity — 15–50%
Healthcare Services Mid (7.1bn) -1–5 -$100K–$1M -0–15% 50%+
Healthcare Services Mid (7.0bn) 1–5 $10M–$100M 0–15% 50%+
Pharmaceuticals & Medical Research Mid (7.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 0–15%
US Merus NV (MRUS)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 50%+
NL Qiagen NV (QIA)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 0–15%
IE Alkermes Plc (ALKS)
Pharmaceuticals & Medical Research Mid (6.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Medicines Co (MDCO)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — —
US Arcellx, Inc. (ACLX)
Pharmaceuticals & Medical Research Mid (6.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.7bn) 0 No activity — 0–15%
Healthcare Services Mid (6.7bn) -1–5 -$1M–$10M -0–15% 0–15%
SE Getinge AB (GETI-B)
Healthcare Services Mid (6.6bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (6.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.4bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) -1–5 -$10M–$100M -0–15% 0–15%